ViiV's HIV Drug Recommended for EU Approvalread allhere |
|||
ViiV Healthcare, the HIV company
established by GlaxoSmithKline and Pfizer in 2009, announced that the
Committee for Medicinal Products for Human Use (CHMP) of the EMA has
recommended marketing authorization for Tivicay (dolutegravir) for use in
combination with other antiretroviral medicinal products for the treatment of
HIV-infected patients. How soon could the drug be approved in the EU? Find
out...
|
Tuesday, 26 November 2013
ViiV's HIV Drug Recommended for EU Approval
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment